Veterinary Medicine Information website

Vanguard CPV-Lepto Suspensie voor injectie

Authorised
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
  • Canine parvovirus, strain NL-35-D, Live
Download as PDF

Product identification

Medicine name:
Vanguard CPV-Lepto Suspensie voor injectie
Active substance:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
  • Canine parvovirus, strain NL-35-D, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
    40.00
    Hamster protective Dose 80%
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
    40.00
    Hamster protective Dose 80%
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain NL-35-D, Live
    10000000.00
    50% cell culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AL04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Vanguard CPV-Lepto 25 Vials with 1 dose of Suspension for injection
  • Vanguard CPV-Lepto 100 Vials with 1 dose of Suspension for injection
  • Vanguard CPV-Lepto 10 Vials with 1 dose of Suspension for injection
  • Vanguard CPV-Lepto 1 Vial with 1 dose of Suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V161551
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 18/08/2025
Download
Dutch (PDF)
Published on: 18/08/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download
Dutch (PDF)
Published on: 18/08/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 18/08/2025
Download
German (PDF)
Published on: 18/08/2025
Download
Dutch (PDF)
Published on: 18/08/2025
Download